NASDAQ:GH Guardant Health (GH) Stock Price, News & Analysis $166.66 +4.07 (+2.50%) Closing price 10/21/2026 04:00 PM EasternExtended Trading$166.50 -0.16 (-0.10%) As of 07:41 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Guardant Health Stock (NASDAQ:GH) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Guardant Health alerts:Sign Up Key Stats Today's Range$162.00▼$171.2250-Day Range$157.21▼$187.2252-Week Range$66.59▼$191.05Volume2.54 million shsAverage Volume1.74 million shsMarket Capitalization$22.37 billionP/E RatioN/ADividend YieldN/APrice Target$190.00Consensus RatingModerate Buy Company Overview Guardant Health, Inc. (NASDAQ:GH) is a precision oncology company that develops blood-based tests and data solutions designed to help detect cancer, guide treatment decisions and monitor patients over time. Its technologies analyze circulating tumor DNA and other molecular information from blood samples, supporting more accessible and less invasive alternatives to some tissue-based testing approaches. The company’s products include Guardant360, which helps identify genomic alterations in advanced cancers and may inform targeted treatment selection; Guardant360 Response, designed to assess a patient’s response to therapy; and Guardant Reveal, which is used to detect minimal residual disease and recurrence risk in certain cancers. Guardant Health also offers Shield, a blood-based screening test for colorectal cancer, as well as data and software services for biopharmaceutical companies conducting research and developing oncology treatments. Guardant Health was founded in 2012 by Helmy Eltoukhy and AmirAli Talasaz and is headquartered in Palo Alto, California. The company serves healthcare providers, patients, biopharmaceutical companies and researchers, primarily in the United States, while also supporting cancer testing and research activities in international markets. Its leadership includes co-founder AmirAli Talasaz, who has served as chief executive officer, and co-founder Helmy Eltoukhy, who has held senior leadership and board roles.AI Generated. May Contain Errors. Read More Guardant Health Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks52nd Percentile Overall ScoreGH MarketRank™: 2.57810413885 of 5 starsGuardant Health scored higher than 52% of companies evaluated by MarketBeat, and ranked 479th out of 903 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.6 / 5Analyst RatingModerate Buy Consensus RatingGuardant Health has received a consensus rating of Moderate Buy. The company's average rating score is 2.96, and is based on 1 strong buy rating, 23 buy ratings, no hold ratings, and 1 sell rating.Upside PotentialGuardant Health has a consensus price target of $190.00, representing about 14.0% upside from its current price of $166.66.Amount of Analyst CoverageGuardant Health has been the subject of 16 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Guardant Health's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Guardant Health are expected to grow in the coming year, from ($3.02) to ($2.06) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Guardant Health is -47.75, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Guardant Health is -47.75, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Read more about Guardant Health's valuation and earnings. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted9.41% of the float of Guardant Health has been sold short.Short Interest Ratio / Days to CoverGuardant Health has a short interest ratio ("days to cover") of 6.2.Change versus previous monthShort interest in Guardant Health has recently increased by 8.14%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldGuardant Health does not currently pay a dividend.Dividend GrowthGuardant Health does not have a long track record of dividend growth. News and Social Media3.5 / 5News Sentiment0.55 News SentimentGuardant Health has a news sentiment score of 0.55. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.News Coverage This WeekMarketBeat has tracked 23 news articles for Guardant Health this week, compared to 8 articles on an average week.Search Interest16 people have searched for GH on MarketBeat in the last 30 days. This is an increase of 14% compared to the previous 30 days.MarketBeat Follows16 people have added Guardant Health to their MarketBeat watchlist in the last 30 days. This is an increase of 300% compared to the previous 30 days. Company Ownership1.6 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Guardant Health insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $30,070,911.00 in company stock.Percentage Held by Insiders5.60% of the stock of Guardant Health is held by insiders.Percentage Held by Institutions92.60% of the stock of Guardant Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Guardant Health's insider trading history. Receive GH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Guardant Health and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. GH Stock News HeadlinesGuardant Health, Inc. (NASDAQ:GH) Stock Has Consensus Price Target of $190.00October 22 at 2:44 AM | americanbankingnews.comGuardant Health Highlights Broad Liquid Biopsy Research Portfolio at ESMO Congress 2026October 20 at 2:18 PM | marketscreener.comMYour Social Security check is scheduled for a 22% cutThe U.S. now borrows money just to pay interest on money it already borrowed, a pattern economists call a debt death spiral. Interest payments alone now top a trillion dollars a year. The Social Security trust fund is projected to run dry by 2032, which could trigger an automatic 22% cut to benefits. Between 2020 and 2022, the Fed expanded the money supply by 41%. A free 27 page report breaks down these numbers in plain English, including what central banks have been doing with gold.October 22 at 1:00 AM | American Alternative (Ad)Guardant Health (GH) Wins a New Breast Cancer Role. Can Its Growth Justify the Price?October 20 at 12:51 PM | insidermonkey.comGuardant Health (NASDAQ:GH) Director Musa Tariq Sells 116 Shares of StockOctober 20 at 4:38 AM | americanbankingnews.comGuardant Health (NASDAQ:GH) Director Musa Tariq Sells 116 Shares of Company StockOctober 20 at 4:37 AM | insidertrades.comThe AI Trade Just Moved Into Your Bloodstream, and 4 Healthcare Stocks Are Winning (GH)AI-driven "biointelligence" is reshaping healthcare investing, with Guardant Health, Illumina, Eli Lilly and Moderna emerging as key stocks as data-driven testing, sequencing and therapies compound.October 19 at 10:30 AM | marketbeat.comInsider Selling: Guardant Health (NASDAQ:GH) Director Sells 69 Shares of Company StockOctober 16, 2026 | insidertrades.comSee More Headlines GH Stock Analysis - Frequently Asked Questions How have GH shares performed this year? Guardant Health's stock was trading at $102.14 at the beginning of 2026. Since then, GH shares have increased by 63.2% and is now trading at $166.66. How were Guardant Health's earnings last quarter? Guardant Health, Inc. (NASDAQ:GH) posted its quarterly earnings data on Thursday, July, 30th. The company reported ($0.42) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.76) by $0.34. Guardant Health's revenue was up 44.3% on a year-over-year basis. Read the conference call transcript. When did Guardant Health IPO? Guardant Health (GH) raised $200 million in an IPO on Thursday, October 4th 2018. The company issued 12,500,000 shares at a price of $15.00-$17.00 per share. J.P. Morgan and BofA Merrill Lynch acted as the underwriters for the IPO and Cowen, Leerink Partners and William Blair were co-managers. Who are Guardant Health's major shareholders? Top institutional investors of Guardant Health include TD Waterhouse Canada Inc. (0.03%), Triasima Portfolio Management inc. (0.03%), Krilogy Financial LLC (0.02%) and Nisa Investment Advisors LLC (0.01%). Insiders that own company stock include Helmy Eltoukhy, Darya Chudova, Chris Freeman, Michael Brian Bell, Amirali Talasaz, John G Saia, Terilyn J Monroe, Myrtle S Potter, Kumud Kalia, Musa Tariq, Meghan V Joyce, Steve E Krognes, Medina Manuel Hidalgo, Ian T Clark and Alex M Azar II. View institutional ownership trends. How do I buy shares of Guardant Health? Shares of GH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Guardant Health own? Based on aggregate information from My MarketBeat watchlists, some other companies that Guardant Health investors own include NVIDIA (NVDA), Shopify (SHOP), Trade Desk (TTD), Advanced Micro Devices (AMD), Micron Technology (MU), Tesla (TSLA) and Twilio (TWLO). Company Calendar Last Earnings7/30/2026Today10/22/2026Next Earnings (Confirmed)11/05/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (5m+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 GH's financial health is in the Green zone, according to TradeSmith. GH has been in this zone for over 5 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Providers & Services Sub-IndustryHealthcare Services Current SymbolNASDAQ:GH CIK1576280 Webwww.guardanthealth.com Phone(855) 698-8887Fax888-974-4258Employees2,506Year Founded2012Price Target and Rating Average Price Target for Guardant Health$190.00 High Price Target$225.00 Low Price Target$120.00 Potential Upside/Downside+14.0%Consensus RatingModerate Buy Rating Score (0-4)2.96 Research Coverage25 Analysts Profitability EPS (Trailing Twelve Months)($3.49) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$416.28 million Net Margins-38.33% Pretax Margin-38.41% Return on EquityN/A Return on Assets-25.40% Debt Debt-to-Equity RatioN/A Current Ratio4.03 Quick Ratio3.71 Sales & Book Value Annual Sales$982.02 million Price / Sales22.78 Cash FlowN/A Price / Cash FlowN/A Book Value($0.79) per share Price / Book-210.96Miscellaneous Outstanding Shares134,200,000Free Float126,681,000Market Cap$22.37 billion OptionableOptionable Beta1.58 Social Links 7 Stocks to Buy Before the Robotics RevolutionRobotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.Get This Free Report This page (NASDAQ:GH) was last updated on 10/21/2026 by MarketBeat.com Staff. From Our PartnersMicroscopic footage reveals immune cells destroying cancer cellsTime-lapse footage from a recent clinical study shows Natural Killer cells attacking and eliminating cancer ce...Market Tactic | Sponsored80 Days Until the Pentagon Restricts Chinese Rare EarthsChina controls more than 90% of global rare earth alloy production, leverage it is using to restrict exports t...The Tomorrow Investor | SponsoredFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American financial crashes over his 55-year career leadin...Weiss Ratings | Sponsored$40,000,000,000,000The national debt just hit 40 trillion dollars, and the U.S. now spends more on interest payments than on its ...American Alternative | SponsoredBeginner’s Guide to GoldInflation, trade wars, and market volatility have many savers rethinking how they protect retirement funds. A ...Goldco Direct, LLC | SponsoredDon't lose access to thisIan Cooper is giving away his guide, The Simple Path To Success With Options, before it moves behind a paywall...TradeWins | SponsoredThis free guide explains options the way they should be taughtMost options educators jump straight into Greeks, spreads, and implied volatility - losing beginners before th...Base Camp Trading | SponsoredTrump’s Plan To Cheat HistoryChina has slashed its U.S. Treasury holdings by more than 45% from their peak, while building gold vaults and ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Guardant Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Guardant Health With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
